In tumor-bearing mice, pharmacologic inhibition of PAD4 with the selective small molecule inhibitor JBI-589 can result in reduced CXCR2 expression and block neutrophil chemotaxis [84]. The gene discussed is PADI4; the disease is neoplasm.